Literature DB >> 1371029

Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris.

X J Yao1, M A Wainberg, M A Parniak.   

Abstract

Crude extracts of four Chinese herbs, Arctium lappa, Astragalus membranaceus, Andrographis paniculata, and Prunella vulgaris, were assessed in several tissue culture lines for anti-HIV activity and for cytotoxicity. One extract, obtained from P. vulgaris, was able to significantly inhibit HIV-1 replication with relatively low cytotoxicity. The active factor was purified using sequential precipitations with ethanol and n-butanol, followed by reverse-phase and gel permeation high-performance liquid chromatographic separations. The active component was anionic with a molecular weight of approximately 10 kDa. The purified extract inhibited HIV-1 replication in the lymphoid cell line MT-4, in the monocytoid cell line U937, and in peripheral blood mononuclear cells at effective concentrations of 6, 30, and 12.5 micrograms/ml, respectively. Pretreatment of uninfected cells with the extract prior to viral exposure did not prevent HIV-1 infection. By contrast, preincubation of HIV-1 with the purified extract dramatically decreased infectiousness. The purified extract was also able to block cell-to-cell transmission of HIV-1, prevented syncytium formation, and interfered with the ability of both HIV-1 and purified gp120 to bind to CD4. PCR analysis confirmed the absence of HIV-1 proviral DNA in cells exposed to virus in the presence of the extract. These results suggest that the purified extract antagonizes HIV-1 infection of susceptible cells by preventing viral attachment to the CD4 receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371029     DOI: 10.1016/0042-6822(92)90294-y

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

Review 1.  Plant products as antimicrobial agents.

Authors:  M M Cowan
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

Review 2.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

3.  Inhibition of proprotein convertases-1, -7 and furin by diterpines of Andrographis paniculata and their succinoyl esters.

Authors:  A Basak; S Cooper; A G Roberge; U K Banik; M Chrétien; N G Seidah
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

4.  Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase.

Authors:  G Borkow; J Barnard; T M Nguyen; A Belmonte; M A Wainberg; M A Parniak
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide.

Authors:  W F Chiou; C F Chen; J J Lin
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

6.  A tight-binding mode of inhibition is essential for anti-human immunodeficiency virus type 1 virucidal activity of nonnucleoside reverse transcriptase inhibitors.

Authors:  Dimitrios Motakis; Michael A Parniak
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  The thiocarboxanilide nonnucleoside inhibitor UC781 restores antiviral activity of 3'-azido-3'-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus type 1.

Authors:  G Borkow; D Arion; M A Wainberg; M A Parniak
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

8.  Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L.

Authors:  ChoonSeok Oh; Jason Price; Melinda A Brindley; Mark P Widrlechner; Luping Qu; Joe-Ann McCoy; Patricia Murphy; Cathy Hauck; Wendy Maury
Journal:  Virol J       Date:  2011-04-23       Impact factor: 4.099

9.  Inhibition of HCV 3a core gene through Silymarin and its fractions.

Authors:  Usman Ali Ashfaq; Tariq Javed; Sidra Rehman; Zafar Nawaz; Sheikh Riazuddin
Journal:  Virol J       Date:  2011-04-01       Impact factor: 4.099

Review 10.  Hepatitis C virus and natural compounds: a new antiviral approach?

Authors:  Noémie Calland; Jean Dubuisson; Yves Rouillé; Karin Séron
Journal:  Viruses       Date:  2012-10-17       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.